Connecticut Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Connecticut Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$478K	Buy	766 +1	+0.1%	+$681	0.02%	241
2026 Q1	$591K	Buy	765 +4	+0.5%	+$3.06K	0.02%	212
2025 Q4	$588K	Buy	761 +4	+0.5%	+$2.72K	0.03%	213
2025 Q3	$426K	Hold	757	–	–	0.02%	241
2025 Q2	$397K	Sell	757 -31	-4%	-$17.3K	0.02%	229
2025 Q1	$500K	Buy	788 +26	+3%	+$17.9K	0.03%	211
2024 Q4	$543K	Buy	762 +4	+0.5%	+$3.36K	0.03%	178
2024 Q3	$797K	Sell	758 -86	-10%	-$95.7K	0.04%	178
2024 Q2	$887K	Sell	844 -165	-16%	-$160K	0.05%	163
2024 Q1	$971K	Buy	1,009 +13	+1%	+$12.4K	0.05%	151
2023 Q4	$875K	Sell	996 -187	-16%	-$154K	0.05%	157
2023 Q3	$974K	Hold	1,183	–	–	0.07%	118
2023 Q2	$850K	Hold	1,183	–	–	0.06%	109
2023 Q1	$972K	Hold	1,183	–	–	0.07%	97
2022 Q4	$854K	Sell	1,183 -1	-0.1%	-$738	0.07%	90
2022 Q3	$816K	Sell	1,184 -1	-0.1%	-$629	0.08%	87
2022 Q2	$700K	Sell	1,185 -3	-0.3%	-$1.95K	0.06%	102
2022 Q1	$830K	Hold	1,188	–	–	0.06%	94
2021 Q4	$750K	Sell	1,188 -2	-0.2%	-$1.23K	0.06%	98
2021 Q3	$720K	Buy	1,190 +174	+17%	+$108K	0.06%	96
2021 Q2	$567K	Hold	1,016	–	–	0.05%	113
2021 Q1	$481K	Hold	1,016	–	–	0.04%	101
2020 Q4	$491K	Sell	1,016 -3	-0.3%	-$1.62K	0.05%	109
2020 Q3	$570K	Buy	1,019 +19	+2%	+$11.5K	0.06%	111
2020 Q2	$624K	Hold	1,000	–	–	0.08%	78
2020 Q1	$488K	Hold	1,000	–	–	0.07%	93
2019 Q4	$375K	Hold	1,000	–	–	0.04%	122
2019 Q3	$277K	Hold	1,000	–	–	0.03%	133
2019 Q2	$313K	Buy	+1,000	New	+$333K	0.04%	124

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Connecticut Wealth Management's REGN Position: Q2 2026 in Review

Connecticut Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 0.13% in Q2 2026, buying an estimated $681 and bringing the position to 766 shares worth $478K. The position accounts for 0.02% of the portfolio, ranked #241.

Connecticut Wealth Management first reported a position in REGN in Q2 2019 and has held it in 29 quarters since. The position peaked at $974K in Q3 2023. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Connecticut Wealth Management held 766 shares of Regeneron Pharmaceuticals worth $478K as of Q2 2026.
Connecticut Wealth Management bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
Regeneron Pharmaceuticals made up 0.02% of Connecticut Wealth Management's portfolio in Q2 2026, its #241 holding.
Connecticut Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
Connecticut Wealth Management's Regeneron Pharmaceuticals position peaked at $974K in Q3 2023.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Connecticut Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.